(Q42656368)
Statements
A randomized study to demonstrate noninferiority of once-daily OROS(®) hydromorphone with twice-daily sustained-release oxycodone for moderate to severe chronic noncancer pain (English)
Heinrich Binsfeld
Leszek Szczepanski
Sandra Waechter
1 September 2010